人TIMP-2蛋白在肝癌细胞迁移与侵袭中的作用

doi:10.6040/j.issn.1671-7554.0.2016.132

摘要/Abstract

摘要： 目的通过原核表达获取人TIMP-2蛋白,探讨TIMP-2在肝癌细胞迁移及侵袭中的作用。方法以SMMC-7721肝癌细胞总RNA为模板,用RT-PCR技术扩增出人TIMP-2基因cDNA,通过基因重组技术构建原核表达载体pGEX-TIMP-2并在大肠杆菌Origami(DE3)中诱导表达人TIMP-2重组蛋白。采用亲和层析法纯化表达产物,并用Western blotting鉴定;用RNAi技术和添加外源蛋白方法分析TIMP-2蛋白对肝癌细胞迁移和侵袭的作用;荧光定量PCR 、Western blotting检测siRNA-TIMP-2转染细胞后肝癌细胞内源性TIMP-2的mRNA及蛋白表达水平。结果外源添加的TIMP-2 蛋白抑制肝癌细胞迁移及侵袭的能力,而RNAi技术能抑制内源的TIMP-2蛋白增强肝癌细胞迁移及侵袭的能力;肝星状细胞的条件培养液能够促进肝癌细胞迁移和侵袭,而这种作用能够被TIMP-2蛋白抑制。结论肝癌微环境中的TIMP-2蛋白水平与肝癌细胞的迁移和浸润密切相关。

关键词: 肝细胞癌, 侵袭, 转移, 基质金属蛋白酶抑制剂2

Abstract: Objective To collect protein of human TIMP-2 through prokaryotic expression in vitro, and to explore its role in the migration and invasion of hepatocellular carcinoma(HCC)cell. Methods Total RNA was extracted from human hepatoma cell line SMMC-7721, and TIMP-2 cDNA was obtained with RT-PCR. The prokaryotic expression vector pGEX-TIMP-2 was constructed, and then transformed into Origami(DE3). The expressional product was purified with affinity chromatography and identified with Western blotting. The role of TIMP-2 in migration and invasion of HCC cells were detected with RNAi technology and adding extraneous TIMP-2 protein. The mRNA and protein expressions of endogenous TIMP-2 in HCC cells were detected with real-time fluorescence quantitative PCR and Western blotting after transfection with siTIMP-2. Results Adding of exogenous TIMP-2 suppressed the migration and invasion of HCC; knock-down of TIMP-2 enhanced the migration and invasion of HCC; conditioned medium of hepatic stellate cells promoted the migration and invasion of HCC, which could be inhibited by TIMP-2 protein. Conclusion The level of TIMP-2 protein in the microenvironment is closely related to the migration and invasion of HCC.

Key words: Tissue inhibitor of matrix metalloproteinases-2, Invasion, Hepatocellular carcinoma, Migration

中图分类号:

R735.7

王伟,曹煜姗,孙达权,黄小琼,徐国强. 人TIMP-2蛋白在肝癌细胞迁移与侵袭中的作用[J]. 山东大学学报（医学版）, 2016, 54(7): 11-17.

WANG Wei, CAO Yushan, SUN Daquan, HUANG Xiaoqiong, XU Guoqiang. Role of human TIMP-2 protein in the migration and invasion of hepatocellular carcinoma cell[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(7): 11-17.

参考文献

[1] Morise Z, Kawabe N, Tomishige H, et al. Recent advances in liver resection for hepatocellular carcinoma[J]. Front Surg, 2014, 1: 21. doi: 10.3389/fsurg.2014.00021.
[2] Giannelli G, Rani B, Dituri F, et al. Moving towards personalised therapy in patients with hepatocellular carcinoma: the role of the microenvironment[J]. Gut, 2014, 63(10): 1668-1676.
[3] Cirri P, Chiarugi P. Cancer-associated-fibroblasts and tumor cells: a diabolic liaison driving cancer progression[J]. Cancer Metastasis Rev, 2012, 31(1-2): 195-208.
[4] Amann T, Bataille F, Spruss T, et al. Activated hepatic stellate cellss promote tumorigenicity of hepatocellular carcinoma[J]. Cancer Sci, 2009, 100(4): 646-653.
[5] Yang SF, Chen MK, Hsieh YS, et al. Antimetastatic effects of Terminalia catappa L. on oral cancer via a down-regulation of metastasis-associated proteases[J]. Food Chem Toxicol, 2010, 48(4): 1052-1058.
[6] Yeh CB, Hsieh MJ, Hsieh YH, et al. Antimetastatic effects of norcantharidin on hepatocellular carcinoma by transcriptional inhibition of MMP-9 through modulation of NF-kB activity[J]. PLoS One, 2012, 7(2): e31055. doi: 10.1371/journal.pone.0031055.
[7] Breitkreutz D, Koxholt I, Thiemann K, et al. Skin basement membrane: the foundation of epidermal integrity-BM functions and diverse roles of bridging molecules nidogen and perlecan[J]. Biomed Res Int, 2013, 2013: 179784. doi:10.1155/2013/179784.
[8] Stetler-Stevenson WG, Gavil NV. Normalization of the tumor microenvironment: evidence for tissue inhibitor of metalloproteinase-2 as a cancer therapeutic[J]. Connect Tissue Res, 2014, 55(1): 13-19.
[9] Shao J, Xu Z, Peng X, et al. Gefitinib synergizes with irinotecan to suppress hepatocellular carcinoma via antagonizing rad51-mediated DNA-repair[J]. PLoS One, 2016, 11(11): e0146968. doi: 10.1371/journal.pone.0146968.
[10] Johansson E, Komuro A, Iwata C, et al. Exogenous introduction of tissue inhibitor of metalloproteinase 2 reduces accelerated growth of TGF-beta-disrupted diffuse-type gastric carcinoma[J]. Cancer Sci, 2010, 101(11): 2398-2403.
[11] Mendes O, Kim HT, Lungu G. et al. MMP2 role in breast cancer brain metastasis development and its regulation by TIMP2 and ERK1/2[J]. Clin Exp Metastasis, 2007, 24(5): 341-351.
[12] Liang B, Yin JJ, Zhan XR. MiR-301a promotes cell proliferation by directly targeting TIMP-2 in multiple myeloma[J]. Int J Clin Exp Pathol, 2015, 8(8): 9168-9174.
[13] Dai Y, Xia W, Song T, et al. MicroRNA-200b is overexpressed in endometrial adenocarcinomas and enhances MMP2 activity by downregulating TIMP-2 in human endometrial cancer cell line HEC-1A cells[J]. Nucleic Acid Ther, 2013, 23(1): 29-34.
[14] Zhu M, Zhang N, Zhao L, et al. MicroRNA-106a targets TIMP-2 to regulate invasion and metastasis of gastric cancer[J]. FEBS Lett, 2014, 588(4): 600-607.
[15] Lu GJ, Dong YQ, Jiao LY, et al. MiRNA-221 promotes proliferation, migration and invasion by targeting TIMP-2 in renal cell carcinoma[J]. Int J Clin Exp Pathol, 2015, 8(5): 5224-5229.
[16] Braicu EI, Gasimli K, Richter R, et al. Role of serum VEGFA, TIMP-2, MMP2 and MMP9 in monitoring response to adjuvant radiochemotherapy in patients with primary cervical cancer-results of a companion protocol of the randomized NOGGO-AGO phase III clinical trial[J]. Anticancer Res, 2014, 34(1): 385-391.
[17] Chen TY, Li YC, Liu YF, et al. Role of MMP14 gene polymorphisms in susceptibility and pathological development to hepatocellular carcinoma[J]. Ann Surg Oncol, 2011, 18(8): 2348-2356.
[18] Bourboulia D, Han H, Stetler-Stevenson WG, et al. TIMP-2 modulates cancer cell transcriptional profile and enhances E-cadherin/beta-catenin complex expression in A549 lung cancer cells[J]. Oncotarget, 2013, 4(1): 163-173.

相关文章 15

[1]	殷悦,莫振飞,吴培昕,刘金霞,魏元辉,任佳博,李春笋. GPX1基因在肺癌中的表达特征及其对肺腺癌细胞增殖、迁移、侵袭、凋亡的影响[J]. 山东大学学报 (医学版), 2026, 64(1): 65-73.
[2]	韩觉明,王晖,吴倩,郑慧玲,朱琳. B4GALNT4促进肺腺癌细胞增殖、迁移和侵袭能力[J]. 山东大学学报 (医学版), 2025, 63(7): 23-31.
[3]	张洁,赵颖慧,董雅琪,李娟,李培龙,杜鲁涛. GPR133基因甲基化在早期胃癌淋巴结转移预测中的作用[J]. 山东大学学报 (医学版), 2025, 63(3): 76-84.
[4]	巩洁,于淼,李秀勇,陈颖,徐倩茹,李梅娟,李艺彤,刘秀美. 基于上转换纳米粒子多糖探针的构建及其在肿瘤成像中的应用[J]. 山东大学学报 (医学版), 2025, 63(11): 18-26.
[5]	刘振昆,吕纪玲,徐伟伟,马力天,张才擎. BALF tNGS检测及培养对NSCLC合并IPFD的诊断价值[J]. 山东大学学报 (医学版), 2025, 63(11): 36-45.
[6]	张洁,张芳芳,王靖楠,李泽宇,宋颖,李娜. circ_0000144在乳腺癌中的表达及其对乳腺癌细胞增殖、迁移和侵袭能力的影响[J]. 山东大学学报 (医学版), 2025, 63(1): 35-42.
[7]	孙婧,杨瑞敏,王聪,张月,罗兵. 基于术前超声、炎症指标及超声影像组学联合模型预测乳腺癌腋窝淋巴结转移[J]. 山东大学学报 (医学版), 2025, 63(1): 73-80.
[8]	张学宇,张学海,孙文青,刘晗,姜金波,刘寒,李远,陈晓梅. 重症新型冠状病毒肺炎伴侵袭性肺曲霉病及反复致命性消化道出血1例[J]. 山东大学学报 (医学版), 2024, 62(7): 56-61.
[9]	宋艳艳,左淑英. 透明细胞肾细胞癌颌下腺转移1例并文献复习[J]. 山东大学学报 (医学版), 2024, 62(7): 120-124.
[10]	林雨洋,王蓓,李菲. 大于10 mm甲状腺乳头状癌侧颈区淋巴结转移预测[J]. 山东大学学报 (医学版), 2024, 62(6): 54-64.
[11]	刘爱静,李雁儒,高惠茹,段伟丽,李培龙,李娟,杜鲁涛,王传新. 自噬相关蛋白5在结肠癌中的表达及对结肠癌细胞迁移及侵袭能力的影响[J]. 山东大学学报 (医学版), 2024, 62(4): 14-23.
[12]	吴霖,石晨曦,童星. 肺良性转移性平滑肌瘤病7例并文献复习[J]. 山东大学学报 (医学版), 2024, 62(4): 78-84.
[13]	孙菁果,朱文帅,鲁艺,马晓丽,郏雁飞. 幽门螺杆菌感染对胃癌细胞m6A水平的影响及其机制[J]. 山东大学学报 (医学版), 2023, 61(9): 10-18.
[14]	董雅琪,王新慧,赵颖慧,王传新. 血清外泌体LINC02163作为结直肠癌远处转移标志物的临床价值[J]. 山东大学学报 (医学版), 2023, 61(9): 19-28.
[15]	陈映均,刘同刚. 综合生物信息学分析鉴定乙型肝炎病毒相关肝细胞癌中异常甲基化修饰的差异表达基因[J]. 山东大学学报 (医学版), 2023, 61(9): 101-117.

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed